(2026). Adjunctive Cannabidiol for Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis of Randomized Trials Across Syndromes, Formulations, and Dose Ranges. Therapeutics and Clinical Risk Management.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Adjunctive Cannabidiol for Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis of Randomized Trials Across Syndromes, Formulations, and Dose Ranges."
Therapeutics and Clinical Risk Management 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Adjunctive Cannabidiol for Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis of Randomized Trials Across Syndromes, Formulations, and Dose Ranges."
Therapeutics and Clinical Risk Management, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.